Hepatitis C and nephropathy
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Clinical and Biomedical Research |
Texto Completo: | https://seer.ufrgs.br/index.php/hcpa/article/view/125380 |
Resumo: | OBJECTIVE: Many studies have associated hepatitis C virus infection with extra-hepatic manifestations, including glomerulopathies. Our objective is to present a brief review of the literature regarding renal manifestations of hepatitis C and the summarized results from a study aimed at evaluating the association of asymptomatic urinary abnormalities in anti-HCV positive blood donors. MATERIALS AND METHODS: We carried out a cross- ectional, contemporary, controlled, open study from July 1997 to March 1998 at the Nephrology Services at Hospital de Clínicas de Porto Alegre in order to evaluate the prevalence of asymptomatic urinary abnormalities in hepatitis-C virus carriers. We included 58 blood donors positive for HCV and 128 donors negative for HCV (control group) without history of hepatic or renal disease and without other positive viral markers. We assessed prevalence of hematuria (> 5 red blood cells per high power field in urinary sediment); proteinuria (1 dipstick positive); microalbuminuria (microalbuminuria/creatinine ratio from an isolated sample >15.6 mg/g); and N-acetyl-beta-lucosaminidase (> 5.6 U/g creatinine). RESULTS: The data showed that the group positive for anti-HCV did not present significant urinary abnormalitiies when compared to a control group. The prevalence of hematuria and proteinuria in the HCV+ e HCV- groups was, respectively, 12.0% x 9.4% and 5.4% x 5.6% with no statistically significant differences. CONCLUSION: The prevalence of hematuria was similar to that found in the generalpopulation (3-20%). |
id |
UFRGS-20_1a9e60754673112fe44e059e1bdc68b2 |
---|---|
oai_identifier_str |
oai:seer.ufrgs.br:article/125380 |
network_acronym_str |
UFRGS-20 |
network_name_str |
Clinical and Biomedical Research |
repository_id_str |
|
spelling |
Hepatitis C and nephropathyHepatite C e nefropatiaHepatite Cnefropatiaalterações urinárias assintomáticasHepatitis Cnephropathyasymptomatic urinary abnormalitiesOBJECTIVE: Many studies have associated hepatitis C virus infection with extra-hepatic manifestations, including glomerulopathies. Our objective is to present a brief review of the literature regarding renal manifestations of hepatitis C and the summarized results from a study aimed at evaluating the association of asymptomatic urinary abnormalities in anti-HCV positive blood donors. MATERIALS AND METHODS: We carried out a cross- ectional, contemporary, controlled, open study from July 1997 to March 1998 at the Nephrology Services at Hospital de Clínicas de Porto Alegre in order to evaluate the prevalence of asymptomatic urinary abnormalities in hepatitis-C virus carriers. We included 58 blood donors positive for HCV and 128 donors negative for HCV (control group) without history of hepatic or renal disease and without other positive viral markers. We assessed prevalence of hematuria (> 5 red blood cells per high power field in urinary sediment); proteinuria (1 dipstick positive); microalbuminuria (microalbuminuria/creatinine ratio from an isolated sample >15.6 mg/g); and N-acetyl-beta-lucosaminidase (> 5.6 U/g creatinine). RESULTS: The data showed that the group positive for anti-HCV did not present significant urinary abnormalitiies when compared to a control group. The prevalence of hematuria and proteinuria in the HCV+ e HCV- groups was, respectively, 12.0% x 9.4% and 5.4% x 5.6% with no statistically significant differences. CONCLUSION: The prevalence of hematuria was similar to that found in the generalpopulation (3-20%).OBJETIVOS: Vários estudos associam a infecção crônica pelo vírus da hepatite C a manifestações extra-hepáticas, incluindo glomerulopatias. O objetivo deste artigo é fazer uma breve revisão da literatura sobre as manifestações renais da hepatite C e apresentar os resultados sumarizados de estudo que buscou avaliar a associação de alterações urinárias assintomáticas em doadores de sangue com anticorpos antiVHCHC positivo. MATERIAIS E MÉTODOS: Realizou-se um estudo transversal, contemporâneo, controlado e aberto no período de julho de 1997 a março de 1998 no Serviço de Nefrologia do HCPA para avaliar a prevalência de alterações urinárias assintomáticas em portadores do vírus da hepatite C. Foram incluídos no estudo os 58 doadores de sangue VHC+ e 128 doadores VHC- (grupo controle) que não apresentavam história de doença hepática ou renal ou outros marcadores virais positivos. Avaliou-se a prevalência de hematúria (> 5 hemácias/campo de grande aumento no E.Q.U), proteinúria [uma (+) no exame por fita do E.Q.U], microalbuminúria (índice microalbuminúria/creatininúria em amostra isolada > 15,6 mg/g), N-acetil-beta-D-glucosaminidase (> 5,6U/g creatinina). RESULTADOS: Não foi constatada anormalidade urinária significativa no grupo VHC+, comparativamente com o grupo controle. A prevalência de hematúria e proteinúria nos grupos VHC+ e VHC- foi respectivamente 12,0% x 9,4% e 5,4% x 5,5% , sem diferença estatística entre os 2 grupos. CONCLUSÃO: A prevalência de hematúria foi semelhante à da população geral, que oscila entre 3-20%.HCPA/FAMED/UFRGS2022-06-23info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliado por Paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/125380Clinical & Biomedical Research; Vol. 20 No. 3 (2000): Revista HCPAClinical and Biomedical Research; v. 20 n. 3 (2000): Revista HCPA2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/125380/85233http://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessK. S. Vieira, Cinthia Lacerda, Mariane V. Mussato, Alexandre Gonçalves, Luiz Felipe 2022-09-16T16:33:15Zoai:seer.ufrgs.br:article/125380Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2022-09-16T16:33:15Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.none.fl_str_mv |
Hepatitis C and nephropathy Hepatite C e nefropatia |
title |
Hepatitis C and nephropathy |
spellingShingle |
Hepatitis C and nephropathy K. S. Vieira, Cinthia Hepatite C nefropatia alterações urinárias assintomáticas Hepatitis C nephropathy asymptomatic urinary abnormalities |
title_short |
Hepatitis C and nephropathy |
title_full |
Hepatitis C and nephropathy |
title_fullStr |
Hepatitis C and nephropathy |
title_full_unstemmed |
Hepatitis C and nephropathy |
title_sort |
Hepatitis C and nephropathy |
author |
K. S. Vieira, Cinthia |
author_facet |
K. S. Vieira, Cinthia Lacerda, Mariane V. Mussato, Alexandre Gonçalves, Luiz Felipe |
author_role |
author |
author2 |
Lacerda, Mariane V. Mussato, Alexandre Gonçalves, Luiz Felipe |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
K. S. Vieira, Cinthia Lacerda, Mariane V. Mussato, Alexandre Gonçalves, Luiz Felipe |
dc.subject.por.fl_str_mv |
Hepatite C nefropatia alterações urinárias assintomáticas Hepatitis C nephropathy asymptomatic urinary abnormalities |
topic |
Hepatite C nefropatia alterações urinárias assintomáticas Hepatitis C nephropathy asymptomatic urinary abnormalities |
description |
OBJECTIVE: Many studies have associated hepatitis C virus infection with extra-hepatic manifestations, including glomerulopathies. Our objective is to present a brief review of the literature regarding renal manifestations of hepatitis C and the summarized results from a study aimed at evaluating the association of asymptomatic urinary abnormalities in anti-HCV positive blood donors. MATERIALS AND METHODS: We carried out a cross- ectional, contemporary, controlled, open study from July 1997 to March 1998 at the Nephrology Services at Hospital de Clínicas de Porto Alegre in order to evaluate the prevalence of asymptomatic urinary abnormalities in hepatitis-C virus carriers. We included 58 blood donors positive for HCV and 128 donors negative for HCV (control group) without history of hepatic or renal disease and without other positive viral markers. We assessed prevalence of hematuria (> 5 red blood cells per high power field in urinary sediment); proteinuria (1 dipstick positive); microalbuminuria (microalbuminuria/creatinine ratio from an isolated sample >15.6 mg/g); and N-acetyl-beta-lucosaminidase (> 5.6 U/g creatinine). RESULTS: The data showed that the group positive for anti-HCV did not present significant urinary abnormalitiies when compared to a control group. The prevalence of hematuria and proteinuria in the HCV+ e HCV- groups was, respectively, 12.0% x 9.4% and 5.4% x 5.6% with no statistically significant differences. CONCLUSION: The prevalence of hematuria was similar to that found in the generalpopulation (3-20%). |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-06-23 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article Avaliado por Pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/125380 |
url |
https://seer.ufrgs.br/index.php/hcpa/article/view/125380 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/125380/85233 |
dc.rights.driver.fl_str_mv |
http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
dc.source.none.fl_str_mv |
Clinical & Biomedical Research; Vol. 20 No. 3 (2000): Revista HCPA Clinical and Biomedical Research; v. 20 n. 3 (2000): Revista HCPA 2357-9730 reponame:Clinical and Biomedical Research instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Clinical and Biomedical Research |
collection |
Clinical and Biomedical Research |
repository.name.fl_str_mv |
Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
||cbr@hcpa.edu.br |
_version_ |
1799767056967532544 |